Previous 10 | Next 10 |
Special poster reception on October 13, 2019 , at Caesars Palace, Las Vegas, the official site of the SAWC Meeting Clinical data demonstrate accelerated healing of diabetic neuropathic foot ulcers with Excellagen wound conforming gel matrix MIRAMAR, Fla., Oct. 10, 2019 (GLOBE NEWSWIR...
Phoenix, Arizona--(Newsfile Corp. - October 7, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personaliz...
MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 15, 2019 at 9:30 am. Joseph Moscato, Generex President & Chief Executive Officer stated...
MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) ( GNBT ) ( http://www.otcmarkets.com/stock/GNBT/quote ), is pleased to announce that their subsidiary, Olaregen Therapeutix, Inc. today officially launched the Excellagen 3.0 cc pre-filled...
AvKare Medical, a Service-Disabled Veteran-Owned Small Business (SDVOSB), is a leading distributor of healthcare products Nationwide distribution and direct sales force to more than 170 VA medical centers and government healthcare facilities Excellagen wound conforming gel matr...
Integrated, collaborative data systems enable population analytics Generex plans to accelerate the clinical development of Oral-Lyn-2 for Type-2 diabetes and Altsulin ® for Type-1 diabetes MIRAMAR, Fla., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corpora...
MIRAMAR, Fla., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the NSABP Foundation, Inc. (NSABP) has enrolled the first patient in the study: A Phase II Clinical Trial...
Retirement of Pool shares will be Reflected in 31.9% reduction in Outstanding Shares MIRAMAR, Fla., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the legal and regu...
President & CEO Joe Moscato and Head of Research Richard Purcell Present the “New” Generex to the Investment Community http://wsw.com/webcast/hcw5/gnbt/index.aspx MIRAMAR, Fla., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) ...
Generex Biotechnology ( OTCQB:GNBT ) has signed letters of intent with Arizona Endocrinology Center and Paradise Valley Family Medicine to establish NuGenerex Health, LLC, a management services organization (MSO) focused on the delivery and management of healthcare services for patients wi...
News, Short Squeeze, Breakout and More Instantly...
Generex Biotechnology Company Name:
GNBT Stock Symbol:
OTCMKTS Market:
Generex Biotechnology Website:
MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Ge...
Ii-Key Immunotherapeutic Vaccine Technology Ii-Key-SARS-CoV-2 Vaccine Market Potential & International Contracts Market Potential for AE37 (Ii-Key-HER2) Immunotherapeutic Vaccine for breast, prostate, and bladder cancers MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) --...
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population. Westside Medicine & Cardiology, Inc. is a professional corporation that engages medical providers who are duly licensed in Ohio ...